PTGX Protagonist Therapeutics, Inc

MIXED Impact: 5/10 Institutional Cluster
Horizon weeks Processed 1d 1h ago
Institutional cluster: 15 buyers, 13 sellers (mixed)

Executive Summary

In Q3 2024, 15 institutions accumulated $54.4M in PTGX (net +$43.4M) while 13 sellers reduced holdings by $267.9M, driven by Farallon Capital's full exit of its $202.4M position. The cluster is dominated by passive/asset-manager buyers and hedge-fund/quant sellers, creating a mixed signal with a bearish net dollar flow.

Key Financial Metrics

Direction
distributing
Buy Value
$54.4M
Sell Value
$267.9M
Net Flow
-$224.5M

Institutional Positions

Net institutional flow: -$224.5M

▲ Buyers (15)

InstitutionActionChangePosition ValueValue Δ
Invesco DOUBLED +638.6% $29.4M $26.3M
Victory Capital Management DOUBLED +1729.3% $5.9M $5.6M
Rhumbline Advisers ADD +93.2% $7.4M $4.4M
Voya Investment Management ADD +75% $5.1M $2.9M
Franklin Resources DOUBLED +127.2% $3.8M $2.5M

▼ Sellers (13)

InstitutionActionChangePrev ValueValue Δ
Farallon Capital Management EXIT -100% $202.4M -$202.4M
Point72 NEAR_EXIT -76.4% $31.5M -$21.9M
Adage Capital Partners Gp TRIM -40% $69.3M -$15.3M
Dimensional Fund Advisors TRIM -63.4% $21.3M -$11.2M
Silvercrest Asset Management G NEAR_EXIT -77.7% $13.2M -$9.4M

Actionable Insight

The massive Farallon exit and Point72 near-exit suggest a loss of conviction from sophisticated investors, likely tied to pipeline setbacks or competitive dynamics. Monitor upcoming clinical data readouts and insider activity for confirmation of thesis deterioration.

Key Facts

  • 15 buyers added $43.4M net; 13 sellers reduced $267.9M net
  • Farallon Capital Management fully exited a $202.4M position (5.84M shares)
  • Point72 cut 76.4% of its stake, selling $21.9M worth
  • Invesco doubled its position to $29.4M (+$26.3M)
  • Victory Capital Management added $5.6M (+1,729% shares)
  • Net institutional flow was heavily negative at -$224.5M

Financial Impact

Net institutional selling of $224.5M in Q3 2024, with buyers adding $43.4M and sellers reducing $267.9M

institutional ownershipfloatshare price

Risk Factors

  • Farallon's full exit may signal fundamental concerns not yet public
  • 13F data is 45+ days stale; positions may have changed since quarter-end
  • Buyers are mostly passive/asset managers, not high-conviction activists

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-PTGX-2024-Q3
6 reports for PTGX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PTGX — sortable, filterable
Type Now
Jun 12, 2026
1d ago
Institutional Cluster
MIXED ★ 5/10
$109.64 awaiting T+5awaiting T+5
May 12, 2026
4w ago
144
BEARISH ★ 5/10
$103.88 $98.37▲ +5.30%▲ +4.15%
May 8, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$99.36 $105.55▲ +6.23%▲ +4.77%
May 8, 2026
5w ago
Insider Cluster
NEUTRAL ★ 5/10
$99.36 $105.55▲ +6.23%▲ +4.77%
May 5, 2026
5w ago
8-K
BULLISH ★ 7/10
$103.97 $99.95▼ −3.87%▼ −5.00%
Feb 25, 2026
15w ago
8-K
MIXED ★ 6/10
$87.10 $94.83▲ +8.87%▲ +9.97%
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (47h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access